Clinical Trial Update: Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for lurbinectedin (PM01183) in selected advanced solid tumors has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Lurbinectedin (lurbinectedin)

Snippet

Sponsor: PharmaMar | Conditions: Advanced Solid Tumors | Phase 2 | Status: COMPLETED | Results posted: 2021-11-22